Thursday, August 29, 2019

USFDA issues warning letter to Lantech Pharma for manufacturing violations at Andhra plant

In a warning letter issued to the company's Managing Director V
Prakash Reddy, the USFDA said inspectors during March 6-15 this year
found significant deviations from standard manufacturing practices at
the company's Ranastalam (Srikakulam district) based plant.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-issues-warning-letter-to-lantech-pharma-for-manufacturing-violations-at-andhra-plant/articleshow/70893574.cms

No comments:

Post a Comment